Gilead | chemanager-online.com - Chemistry and Life Science

May. 27, 2020
News & Opinions
Gilead Licensing Remdesivir Production
Gilead Sciences has tapped five generic drugmakers as partners to further expand supplies of remdesivir, its drug now being trialed in the US as a Covid-19 treatment. ...
Mar. 31, 2020
News & Opinions
Gilead Rescinds Orphan Drug Request
Biopharmaceutical producer Gilead Sciences has surprised the market by asking the US Food and Drug Administration (FDA) to rescind the orphan drug status of its experimental antiviral drug remdesivir only a day after the application was ...
Mar. 04, 2020
News & Opinions
Gilead Boosts Immuno-oncology with Forty Seven
Gilead Sciences has agreed to buy out immuno-oncology company Forty Seven for $4.9 billion. The deal, which has unanimous approval from both boards, is expected to close in the second quarter, pending clearance from antitrust ...
Jul. 23, 2019
News & Opinions
Gilead and Galapagos in Multi-billion Linkup
Galapagos and Gilead Sciences have agreed a ten-year “multi-billion dollar collaboration” to create what they say will be a global R&D leader based in Europe and engaged in developing and commercializing breakthrough ...
Apr. 08, 2019
Topics
The Need for Innovation in Pharmaceutical Manufacturing
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs ...
Oct. 31, 2018
News & Opinions
Gilead HIV Pill Seen to Lower new Infections
An antiviral pill taken daily by thousands of HIV-positive men in Australia has led to a “globally unprecedented” reduction in new infections, according to what is being called “the world’s first study to measure ...
Sep. 04, 2017
News & Opinions
Gilead to pay $12 Billion for Kite Pharma
US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge chimeric antigen therapy treatment for cancer. ...
Jan. 13, 2017
News & Opinions
Pharma Stocks Crash on Trump Pricing Hints
American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an unexpected shock on Jan. 11. On the back of remarks made by the ...
Sep. 05, 2016
News & Opinions
Gilead Sciences Faces Another Hepatitis C Lawsuit
Gilead Sciences is once again preparing to defend itself against a challenge to its hepatitis C intellectual property. The latest lawsuit comes from the University of Minnesota which filed a claim in its district court on Aug. 29, alleging ...
Jul. 26, 2016
News & Opinions
High Drug Prices Said Pressuring US Medicare
Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency Associated Press said provocatively, citing ...

12 3

Register now!

The latest information directly via newsletter.

GIT Verlag